- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | PHAOS TECHNOLOGY HOLDINGS Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 19.02. | Phaos Technology Holdings (Cayman) Limited Provides Updated Response to Unusual Market Action | 8 | GlobeNewswire (USA) | ||
| 05.02. | Phaos Technology Holdings (Cayman) Limited Provides Response to Unusual Market Action | 295 | GlobeNewswire (Europe) | SINGAPORE, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Phaos Technology Holdings (Cayman) Limited, (NYSE American: POAS), ("the Company"), an advanced microscopy solutions headquartered in Singapore, announced... ► Artikel lesen | |
| 16.01. | Phaos Technology Holdings Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 24.11.25 | Phaos Technology Holdings (Cayman) Limited Announces Closing of the Sale of the Option Shares | 301 | GlobeNewswire (Europe) | SINGAPORE, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Phaos Technology Holdings (Cayman) Limited, (NYSE American: POAS), ("Phaos" or "the Company"), an advanced microscopy solutions headquartered in Singapore... ► Artikel lesen | |
| 24.11.25 | Phaos Technology Holdings Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 14.11.25 | Phaos Technology Announces Closing of Initial Public Offering | 373 | GlobeNewswire (Europe) | SINGAPORE, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Phaos Technology Holdings (Cayman) Limited, (NYSE American: POAS), ("Phaos" or "the Company"), the investment holding company of Phaos Technology Pte.... ► Artikel lesen | |
| 13.11.25 | Phaos Technology Prices 2.7 Mln IPO At $4 | 2 | RTTNews | ||
| PHAOS TECHNOLOGY Aktie jetzt für 0€ handeln | |||||
| 13.11.25 | Singapore microscopy tech provider Phaos Technology prices US IPO at the $4 low end | 3 | Renaissance Capital | ||
| 13.11.25 | Phaos Technology announces pricing of initial public offering | 1 | Seeking Alpha | ||
| 13.11.25 | Phaos Technology Announces Pricing of Initial Public Offering | 209 | GlobeNewswire (Europe) | SINGAPORE, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Phaos Technology Holdings (Cayman) Limited, (NYSE American: POAS), ("Phaos" or "the Company"), a leader in advanced microscopy solutions headquartered... ► Artikel lesen | |
| 12.11.25 | Phaos Technology Holdings Ltd - 8-A12B, Registration of securities | - | SEC Filings |
12 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PROCEPT BIOROBOTICS | 23,460 | 0,00 % | PROCEPT BioRobotics to Report First Quarter 2026 Financial Results on April 29, 2026 | ||
| SIEMENS HEALTHINEERS | 38,130 | +0,90 % | ANALYSE-FLASH: Goldman senkt Ziel für Siemens Healthineers - 'Neutral' | NEW YORK (dpa-AFX Broker) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Siemens Healthineers von 52 auf 45 Euro gesenkt, aber die Einstufung auf "Neutral" belassen. Vor der Berichtssaison... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 20,970 | +2,24 % | Alignment Healthcare (ALHC) Soars 16% on Medicare Reimbursement Hike | ||
| BRIGHTSPRING HEALTH SERVICES | 46,060 | 0,00 % | BrightSpring Health Services, Inc. to Announce First Quarter 2026 Financial Results on May 1, 2026 | ||
| ECKERT & ZIEGLER | 15,500 | +3,89 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler sichert Zugang zu entscheidender Augentumorbehandlung durch MDR-Zertifizierung für Ru-106 Augenapplikatoren | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Zulassungsgenehmigung
Eckert & Ziegler sichert Zugang zu entscheidender Augentumorbehandlung durch MDR-Zertifizierung für Ru-106... ► Artikel lesen | |
| FRESENIUS | 44,740 | +0,56 % | EQS-News: Fresenius SE & Co. KGaA: FutureFresenius zahlt sich aus: S&P Global Ratings hebt Ausblick für Fresenius SE von stabil auf positiv an | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Rating
FutureFresenius zahlt sich aus: S&P Global Ratings hebt Ausblick für Fresenius SE von stabil auf positiv an
08.04.2026... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,240 | +0,55 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| PROGYNY | 16,970 | +4,11 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| HEARTFLOW | 27,460 | 0,00 % | Heartflow, Inc.: Heartflow Files Patent Infringement Lawsuit Against Cleerly | MOUNTAIN VIEW, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that it has filed... ► Artikel lesen | |
| ADAPTHEALTH | 12,310 | 0,00 % | AdaptHealth refinances $1.1B senior secured credit facility | ||
| BILLIONTOONE | 78,66 | 0,00 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| BETA BIONICS | 10,640 | +19,82 % | Beta Bionics, Inc.: Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026 | IRVINE, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| SANARA MEDTECH | 17,610 | 0,00 % | Sanara MedTech Inc. Reports Unaudited Preliminary Financial Results for the Fourth Quarter and Full Year 2025; Introduces Full Year 2026 Financial Guidance | FORT WORTH, TX, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara MedTech," "Sanara," the "Company," "we," "our" or "us") (Nasdaq: SMTI), a medical technology company focused on developing... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 23,020 | +2,91 % | What Makes Privia Health (PRVA) One of the Best Mid-Cap Growth Stocks to Invest in | ||
| GENEDX | 61,00 | 0,00 % | Cathie Wood's ARK sells BWX Technologies stock, buys GeneDx |
Das Unternehmen PHAOS TECHNOLOGY HOLDINGS CAYMAN LIMITED kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 1,890 Euro und damit -1,05 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PHAOS TECHNOLOGY HOLDINGS CAYMAN LIMITED finden Sie auf Wallstreet Online.